Human placenta-derived mesenchymal stem cells trigger repair system in TAA-injured rat model via antioxidant effect

Jeeyoon Na1, Joseph Song2, Hyun Ho Kim3

  • 1Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Aging
|January 6, 2021
PubMed

Insights

Placenta-derived mesenchymal stem cells (PD-MSCs) transplantation protected against thioacetamide-induced liver and ovary damage in rats. PD-MSCs activated antioxidant factors, promoting organ regeneration and suggesting therapeutic potential for degenerative diseases.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Toxicology

Background:

  • Oxidative stress, an imbalance between reactive oxygen species (ROS) and detoxification, causes cell and tissue damage.
  • Thioacetamide (TAA) induces degenerative diseases via oxidative stress, but stem cell antioxidant mechanisms in TAA-injured models are understudied.

Purpose of the Study:

  • To investigate the antioxidant effects of placenta-derived mesenchymal stem cells (PD-MSCs) in thioacetamide (TAA)-induced liver and ovarian damage in a rat model.

Main Methods:

  • Rats were induced with TAA to cause liver and ovarian damage.
  • Placenta-derived mesenchymal stem cells (PD-MSCs) were transplanted into TAA-injured rats (Tx group).
  • Compared PD-MSCs engraftment, inflammatory factors, oxidative stress markers, antioxidant factors, and organ function between Tx and non-transplanted (NTx) groups.

Main Results:

  • PD-MSCs successfully engrafted into damaged liver and ovarian tissues in the Tx group.
  • PD-MSC transplantation significantly reduced inflammatory factors and upregulated oxidative stress factors in Tx rats compared to NTx rats.
  • Transplanted PD-MSCs enhanced antioxidant factors and promoted organ functional restoration in TAA-injured rats.

Conclusions:

  • PD-MSC transplantation activates antioxidant factors, triggering regeneration of TAA-induced damaged organs like the liver and ovary.
  • These findings highlight the therapeutic potential of PD-MSCs for degenerative diseases driven by oxidative stress.
  • The study elucidates the therapeutic mechanisms of PD-MSCs in damaged tissues, particularly the liver and reproductive system.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.0K